Open-Label, limited access protocol of Posaconazole in invasive fungal infections.
Phase 1
- Conditions
- Profilaxys of invasive mycotic infections in high risk neutropenic patients.MedDRA version: 6.1 Level: PT Classification code 10017533
- Registration Number
- EUCTR2005-003717-33-IT
- Lead Sponsor
- SCHERING-PLOUGH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method